Search Grant Opportunities

DoD Breast Cancer, Transformative Breast Cancer Consortium Development Award

ID: HT9425-23-BCRP-TBCCDA • Type: Posted

Description

The FY23 Transformative Breast Cancer Consortium Development Award is intended to provide successful applicants the time and resources needed to bring investigators and breast cancer advocates together to establish a consortium framework and conduct preliminary research to support application to a future, full Transformative Breast Cancer Consortium Award (pending availability of funds). This is a development award and is a separate mechanism from the full consortium award. Recipients of the FY23 Transformative Breast Cancer Consortium Development Award are expected to submit an application to compete for the full Transformative Breast Cancer Consortium Award anticipated to be offered in a future fiscal year(s). However, it is not necessary to receive a development award in order to apply for a full consortium award in the future. For FY23, investigators may be named as Consortium Director on an application submitted to either (but not both) of these mechanisms. Detailed information on the FY23 Transformative Breast Cancer Consortium Award is available under a separate program announcement (HT945-23-BCRP-TBCCA).

The FY23 Transformative Breast Cancer Consortium Development Award provides support to:

Develop the infrastructure of a multi-institutional research team inclusive of scientists, clinicians, and breast cancer advocates (e.g., building appropriate collaborations, outlining integration, research management, administrative management, and communication plans, and devising an intellectual property plan)

Generate necessary preliminary data to serve as proof of concept or for project integration

Acquire research resources

Develop a framework of necessary statistical analyses

Breast cancer consumer advocates must be active participants in the development and execution of the Transformative Breast Cancer Consortium Development Award.

A congressionally mandated Metastatic Cancer Task Force was formed with the purpose of identifying ways to help accelerate clinical and translational research aimed at extending the lives of advanced state and recurrent patients. As a member of the Metastatic Cancer Task Force, the CDMRP encourages applicants to review the recommendations (https://health.mil/Reference-Center/Congressional-Testimonies/2018/05/03/Metastatic-Cancer- Research) and submit research ideas to address these recommendations provided they are within the limitations of this funding opportunity and fit within the FY23 BCRP priorities.

Background
The FY23 Transformative Breast Cancer Consortium Development Award is intended to provide successful applicants the time and resources needed to bring investigators and breast cancer advocates together to establish a consortium framework and conduct preliminary research to support application to a future, full Transformative Breast Cancer Consortium Award. The Breast Cancer Research Program (BCRP) was initiated in FY92 to support innovative, high-impact research, with a mission of ending breast cancer for Service Members, Veterans, and the general public. The BCRP challenges the scientific community to design research that will address the urgency of ending breast cancer.

The program encourages collaborations between researchers at military or Veteran institutions and non-military institutions.

Grant Details
The FY23 Transformative Breast Cancer Consortium Development Award provides support to: develop the infrastructure of a multi-institutional research team inclusive of scientists, clinicians, and breast cancer advocates; generate necessary preliminary data to serve as proof of concept or for project integration; acquire research resources; develop a framework of necessary statistical analyses. Breast cancer consumer advocates must be active participants in the development and execution of the award.

The proposed research must be relevant to active-duty Service Members, Veterans, military beneficiaries, and/or the American public. The types of awards made under the program announcement will be assistance agreements. The anticipated direct costs budgeted for the entire period of performance should not exceed $100,000.

Eligibility Requirements
All organizations, including foreign organizations, foreign public entities, and international organizations are eligible to apply. Independent investigators at all academic levels (or equivalent) are eligible to be named as the Consortium Director on an application. Government agencies within the United States are eligible if applications do not overlap with their fully funded internal programs.

Period of Performance
The period of performance for an FY23 BCRP Transformative Breast Cancer Consortium Development Award should not exceed $100,000. Awards will be made no later than September 30, 2024.

Grant Value
$0.31M is expected to fund approximately two Transformative Breast Cancer Consortium Development Award applications.
Show All

Overview

Agency
U.S. Army Medical Research Acquisition Activity (USAMRAA) [DoD - USA - MEDCOM - MRDC]
Category of Funding
Science and Technology and other Research and Development
Funding Instruments
Cooperative Agreement
Grant
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
Grants.gov
On 2/6/23 U.S. Army Medical Research Acquisition Activity posted grant opportunity HT9425-23-BCRP-TBCCDA for DoD Breast Cancer, Transformative Breast Cancer Consortium Development Award with funding of $310,000. The grant will be issued under grant program 12.420 Military Medical Research and Development. It is expected that 2 total grants will be made.

Timing

Posted Date
Feb. 6, 2023, 12:00 a.m. EST
Closing Date
April 11, 2023, 12:00 a.m. EDT Past Due
Last Updated
Feb. 6, 2023, 9:16 a.m. EST
Version
1
Archive Date
May 11, 2023

Eligibility

Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Award Sizing

Ceiling
Not Listed
Floor
Not Listed
Estimated Program Funding
$310,000
Estimated Number of Grants
2

Contacts

Contact
Jamie Shortall Grant Officer
Contact Email
help@ebrap.org   Profile
Email Description
CDMRP Help Desk
Contact Phone
(301) 619-2393

Documents

Posted documents for HT9425-23-BCRP-TBCCDA

Potential Applicants and Partners

Awardees that have recently won grants similar to HT9425-23-BCRP-TBCCDA

Incumbent or Similar Grants

Grants similar to HT9425-23-BCRP-TBCCDA

Similar Active Opportunities

Open grant opportunities similar to HT9425-23-BCRP-TBCCDA